DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie


Patrikidou A, Chabaud S, Ray-Coquard I et al.
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.

Ann Oncol 2013;
24: 1087-1093

Download Bibliographical Data

Search in: